vs
Side-by-side financial comparison of Dexcom (DXCM) and Virtu Financial, Inc. (VIRT). Click either name above to swap in a different company.
Dexcom is the larger business by last-quarter revenue ($1.3B vs $1.1B, roughly 1.1× Virtu Financial, Inc.). Virtu Financial, Inc. runs the higher net margin — 31.6% vs 21.2%, a 10.4% gap on every dollar of revenue. On growth, Virtu Financial, Inc. posted the faster year-over-year revenue change (30.7% vs 21.6%). Over the past eight quarters, Virtu Financial, Inc.'s revenue compounded faster (25.7% CAGR vs 12.0%).
Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.
Virtu Financial, Inc. is an American high-frequency trading company. The company went public on the Nasdaq in 2015.
DXCM vs VIRT — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.3B | $1.1B |
| Net Profit | $267.3M | $346.6M |
| Gross Margin | 62.9% | — |
| Operating Margin | 25.6% | 37.4% |
| Net Margin | 21.2% | 31.6% |
| Revenue YoY | 21.6% | 30.7% |
| Net Profit YoY | 153.6% | 82.8% |
| EPS (diluted) | $0.67 | $1.99 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.3B | $1.1B | ||
| Q4 25 | $1.3B | $969.9M | ||
| Q3 25 | $1.2B | $824.8M | ||
| Q2 25 | $1.2B | $999.6M | ||
| Q1 25 | $1.0B | $837.9M | ||
| Q4 24 | $1.1B | $834.3M | ||
| Q3 24 | $994.2M | $706.8M | ||
| Q2 24 | $1.0B | $693.0M |
| Q1 26 | $267.3M | $346.6M | ||
| Q4 25 | $267.3M | $139.9M | ||
| Q3 25 | $283.8M | $77.6M | ||
| Q2 25 | $179.8M | $151.2M | ||
| Q1 25 | $105.4M | $99.7M | ||
| Q4 24 | $151.7M | $94.1M | ||
| Q3 24 | $134.6M | $60.0M | ||
| Q2 24 | $143.5M | $66.6M |
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
| Q1 26 | 25.6% | 37.4% | ||
| Q4 25 | 25.6% | 35.4% | ||
| Q3 25 | 20.1% | 21.8% | ||
| Q2 25 | 18.4% | 34.7% | ||
| Q1 25 | 12.9% | 26.7% | ||
| Q4 24 | 17.0% | 24.3% | ||
| Q3 24 | 15.3% | 20.8% | ||
| Q2 24 | 15.7% | 22.4% |
| Q1 26 | 21.2% | 31.6% | ||
| Q4 25 | 21.2% | 14.4% | ||
| Q3 25 | 23.5% | 9.4% | ||
| Q2 25 | 15.5% | 15.1% | ||
| Q1 25 | 10.2% | 11.9% | ||
| Q4 24 | 13.6% | 11.3% | ||
| Q3 24 | 13.5% | 8.5% | ||
| Q2 24 | 14.3% | 9.6% |
| Q1 26 | $0.67 | $1.99 | ||
| Q4 25 | $0.67 | $1.54 | ||
| Q3 25 | $0.70 | $0.86 | ||
| Q2 25 | $0.45 | $1.65 | ||
| Q1 25 | $0.27 | $1.08 | ||
| Q4 24 | $0.37 | $1.03 | ||
| Q3 24 | $0.34 | $0.64 | ||
| Q2 24 | $0.35 | $0.71 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $917.7M | $973.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.7B | $2.2B |
| Total Assets | $6.3B | $25.1B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $917.7M | $973.2M | ||
| Q4 25 | $917.7M | $1.1B | ||
| Q3 25 | $1.8B | $707.9M | ||
| Q2 25 | $1.2B | $752.1M | ||
| Q1 25 | $904.9M | $723.6M | ||
| Q4 24 | $606.1M | $872.5M | ||
| Q3 24 | $621.2M | $701.4M | ||
| Q2 24 | $939.2M | $684.8M |
| Q1 26 | — | — | ||
| Q4 25 | — | $2.0B | ||
| Q3 25 | — | $2.0B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.7B | ||
| Q2 24 | — | $1.7B |
| Q1 26 | $2.7B | $2.2B | ||
| Q4 25 | $2.7B | $1.6B | ||
| Q3 25 | $2.7B | $1.5B | ||
| Q2 25 | $2.6B | $1.4B | ||
| Q1 25 | $2.3B | $1.3B | ||
| Q4 24 | $2.1B | $1.3B | ||
| Q3 24 | $2.0B | $1.2B | ||
| Q2 24 | $2.4B | $1.2B |
| Q1 26 | $6.3B | $25.1B | ||
| Q4 25 | $6.3B | $20.2B | ||
| Q3 25 | $7.5B | $21.3B | ||
| Q2 25 | $7.3B | $19.3B | ||
| Q1 25 | $6.8B | $17.5B | ||
| Q4 24 | $6.5B | $15.4B | ||
| Q3 24 | $6.4B | $14.4B | ||
| Q2 24 | $6.8B | $13.9B |
| Q1 26 | — | — | ||
| Q4 25 | — | 1.29× | ||
| Q3 25 | — | 1.40× | ||
| Q2 25 | — | 1.24× | ||
| Q1 25 | — | 1.33× | ||
| Q4 24 | — | 1.39× | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 1.41× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXCM
Segment breakdown not available.
VIRT
| Trading income, net | $789.1M | 72% |
| Commissions, net and technology services | $186.6M | 17% |
| Other | $119.6M | 11% |
